The NAD+ Economy: Inside the Race to Commercialize Cellular Longevity

Mapping the commercial race in cellular longevity.

John Grey — Healthcare & longevity desk

Beta-nicotinamide mononucleotide (β-NMN) is having its moment. Three major trials in 2026 will determine whether this molecule moves from supplement shelf to clinical mainstream.

BlackRock's thematic research flags longevity as one of 5 secular trends reshaping healthcare. The addressable market: $800B by 2035.

But here's the contrarian view: the real value may not be in the molecules themselves—but in delivery mechanisms and biomarker monitoring.

The winners will be those solving bioavailability, not just molecule synthesis.

— Apple Lau, Contributing Editor

Stylized navy world map with a glowing gold fault line bisecting the Atlantic between North America and Europe

The Stablecoin Schism: Why Lagarde's Refusal Matters More Than Bessent's Forecast

Stablecoins hit a record $321bn in April. On the same day, Lagarde rejected euro versions and Bailey promised a wrestle with Washington. The transatlantic split is the trade.

Hong Kong harbour skyline at dusk in soft fog with warm amber light pulse in the foreground

Hong Kong's Comeback Quarter: Why the Mix Matters More Than the Number

HK$110bn raised in Q1 — six times last year. The consensus reads it as A+H momentum. We argue the change in mix, not the headline, is the durable story.

Neoclassical columns receding into deep shadow with a horizontal beam of cold light and muted gold accent

The Words That Survived: Treasury's Quiet Duration Decision

Treasury kept 'at least' in its forward guidance and bill issuance as the load-bearing tool. Q2 needs lifted to $189bn, Q3 to $671bn. We see a stealth duration

Japanese shoji panels with a sweeping currency-curve light streak and crimson accent

Tokyo's Bridge Finance: Why This Yen Intervention Is Not 2024

The April 30 yen intervention is being read as a defensive stopgap. We disagree. With three BoJ dissenters and OIS pricing a 40% June hike, this is bridging fin

Read more

The Stablecoin Schism: Why Lagarde's Refusal Matters More Than Bessent's Forecast

Hong Kong's Comeback Quarter: Why the Mix Matters More Than the Number

The Words That Survived: Treasury's Quiet Duration Decision

Tokyo's Bridge Finance: Why This Yen Intervention Is Not 2024